Glaucoma Implants Market Size, Share, Growth, Trends, and Global Industry Analysis: By Indication (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, and Congenital Glaucoma) By Implant Type (Non-Valved Glaucoma Drainage Implants, Valved Glaucoma Drainage Implants, and Intracameral Implants), By End-Users (Hospitals and Ophthalmology Centers) and Region Forecast 2019-2030

Glaucoma implants market size was valued at US$ 156.8 million in 2023 and is projected to reach US$ 274.3 million by 2030, growing at a CAGR of 8.4% from 2024-2030. In 2023, 374,115 glaucoma implant procedures were performed and are projected to grow at a CAGR of 3.9 % over the forecast years to reach 489,042 procedures by 2030. Moreover, in USA 138,789 glaucoma implant procedures were performed in 2023.

The growing prevalence of glaucoma, especially in age-related disorders, and the technological advancements in minimally invasive glaucoma surgery (MIGS) and implant materials are driving this global market. Increasing awareness, early diagnosis, and government healthcare reforms are further fuelling the progression of the market. High treatment costs, post-surgery complications, and a lack of access to adequate healthcare in developing regions act as prominent restraints in this regard. Improved healthcare infrastructure is likely to help realize growth opportunities in emerging markets, with demand for MIGS devices being one of the key opportunities.

Collaborations between industry players are also a catalyst for innovation. The main trends include a movement towards MIGS, personalized treatments, and smart implants with real-time intraocular pressure monitoring. Healthy growth in investments for research and development and the concept of combination therapies are helpful to patients, presenting drivers for the market despite regulatory challenges and affordability concerns in some regions.

Key Players

The glaucoma implants market share is inclusive of several companies such as Glaukos Corporation, Ocular Therapeutix, Alcon Corporation, Avisi Technologies Inc, iSTAR Medical, Abbvie Inc, Johnson and Johnson, Nova Eye Medical, Advanced Ophthalmic Innovations, and among others.

Key Takeaways

• North America is dominant due to advanced technology and strong industry presence.
• Asia Pacific is the fastest growing due to the high aging population and increasing healthcare expenditure.
• By indication type, the fastest growing and the most dominant segment in the treatment market for glaucoma is open-angle glaucoma, driven by a high prevalence of the disease and a wide array of treatment options.
• By implant type, valved glaucoma drainage implants are a key market winner because they are designed to offer long-term control of IOP with potentially lower complication rates.
• Ophthalmology Centres tend to be the fastest-growing segment, this is primarily due to specialization, advanced technology, and patient preference.

Key Developments

• In July 2020, Nova Eye Medical Limited is an innovative medical technology company that focuses on ophthalmic treatment technologies and devices, it completed the acquisition of certain ophthalmic assets from Molteno Ophthalmic Limited in New Zealand, including the company's proprietary platform of GDDs known as Molteno3®.
• In July 2021, iSTAR Medical SA, the med-tech company developing minimally invasive implants for glaucoma surgery, or MIGS, announced that the FDA had granted the IDE to start a pivotal trial with MINIjectTM. The STAR-V study will recruit over 350 patients suffering from primary open-angle glaucoma to have an investigation of MINIjectTM.
• In May 2022, AbbVie completed the acquisition of Allergan. The $63 billion deal was about diversifying the AbbVie drug lineup, especially upon patent expiry for its blockbuster drug Humira. This acquisition has extensively expanded AbbVie's portfolio by adding the strong presence of Allergan in Xen® Gel Stent, and other neuroscience & aesthetics with popular names like Botox and Juvederm.

Glaucoma Implants Market Segmentation

By Indication Type: The rarest type of Glaucoma is Congenital Glaucoma occurring in infants and young children. Specialists provide them with specific treatments and surgeries in the small congenital glaucoma market.

By Implant Type:  Historically, non-valved implants, such as the Baerveldt, have been very widely used, especially in cases where more aggressive intraocular pressure control needs to be achieved.

By End-user: With ophthalmology among their medical services, hospitals are an excellent choice for all-around care and comprehensive treatment of problems affecting the eye as well as the overall health condition.